RTW Investments’s Pacific Biosciences PACB Stock Holding History

RTW Investments’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,237,607	Closed	-$12.1M	–	53
2018 Q3	$12.1M	Buy	+2,237,607	New	+$9.6M	0.72%	28

Other funds holding PACB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RTW Investments's PACB Position: Q4 2018 in Review

RTW Investments sold out of Pacific Biosciences (PACB) in Q4 2018, closing a stake of 2,237,607 shares — an estimated $12.1M sold.

RTW Investments first reported a position in PACB in Q3 2018 and held it in 1 quarter. The position peaked at $12.1M in Q3 2018. 155 funds tracked by Wall St. Rank hold PACB as of Q4 2018.

RTW Investments reported no remaining Pacific Biosciences position as of Q4 2018 after selling out during the quarter.
RTW Investments sold 2,237,607 Pacific Biosciences shares in Q4 2018, an estimated $12.1M.
RTW Investments first reported a position in Pacific Biosciences in Q3 2018 and held it in 1 quarter.
RTW Investments's Pacific Biosciences position peaked at $12.1M in Q3 2018.
155 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2018.

Based on RTW Investments's 13F filing for Q4 2018, filed 14 Feb 2019.